4
Changes in Ownership
Celldex Therapeutics, Inc. Filed Acc 0001709024-26-000002
SVP AND CFO acquired 4,817 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Martin Samuel Bates SVP AND CFO | 2026-01-02 | Option exercise | +4,817 | $10.38 | $50,000 | 32,942 | D |
| Derivatives | |||||||
| Martin Samuel Bates SVP AND CFO | 2026-01-02 | Option exercise · Incentive Stock Option (Right to Buy) | −4,817 | 58,815 | D | ||
Loading xslF345X05/form4-01062026_090142.xml…